The post Ethereum Faces Year-End Selloff as Quant Programs and Tax-Loss Selling Dominate December Trading appeared on BitcoinEthereumNews.com. In a year-end updateThe post Ethereum Faces Year-End Selloff as Quant Programs and Tax-Loss Selling Dominate December Trading appeared on BitcoinEthereumNews.com. In a year-end update

Ethereum Faces Year-End Selloff as Quant Programs and Tax-Loss Selling Dominate December Trading

In a year-end update, Tom Lee, chair of BitMine, notes that December liquidity typically wanes as institutions trim risk. He argues that end-of-year trading is dominated by quantitative programs and bots, with tax-related stop-loss selling adding to volatility. The observation reflects a common, calendar-driven market pattern in the final trading days, where liquidity conditions and risk-off moves shape price action.

COINOTAG coverage also notes a fresh liquidity signal from CoinShares: last week’s outflow reached $446 million, lifting total outflows since October 10 to about $3.2 billion. The data indicate cautious sentiment and a slow, uneven recovery for digital asset exposure, underscoring the need for disciplined risk management and selective participation by institutional buyers.

Source: https://en.coinotag.com/breakingnews/ethereum-faces-year-end-selloff-as-quant-programs-and-tax-loss-selling-dominate-december-trading

Market Opportunity
TOMCoin Logo
TOMCoin Price(TOM)
$0,000161
$0,000161$0,000161
+5,22%
USD
TOMCoin (TOM) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.